Literature DB >> 8813130

Expression of a translationally regulated, dominant-negative CCAAT/enhancer-binding protein beta isoform and up-regulation of the eukaryotic translation initiation factor 2alpha are correlated with neoplastic transformation of mammary epithelial cells.

B Raught1, A C Gingras, A James, D Medina, N Sonenberg, J M Rosen.   

Abstract

A translationally regulated, dominant-negative isoform of CCAAT/enhancer-binding protein beta is expressed in transplantable and primary mouse mammary tumors of different etiologies but is not expressed in preneoplastic mammary hyperplasias or in primary prostate, lung, lens, ovary or lymphoid tumors. The eukaryotic initiation factor 2alpha protein is also expressed at significantly higher levels (69.8 +/- 7.2%) in these mammary tumors compared with normal and hyperplastic tissues. Thus, misregulation of eukaryotic initiation factor 2alpha may promote the expression of a dominant-negative CCAAT/enhancer-binding protein beta isoform, which may inhibit terminal differentiation and facilitate uncontrolled proliferation of mammary epithelial cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8813130

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  38 in total

1.  Novel tumor antigens elicit anti-tumor humoral immune reactions in a subset of patients with polycythemia vera.

Authors:  Zeyu Xiong; Yan Yan; Enli Liu; Richard T Silver; Srdan Verstovsek; Fan Yang; Hong Wang; Josef Prchal; Xiao-Feng Yang
Journal:  Clin Immunol       Date:  2006-11-17       Impact factor: 3.969

2.  C/EBPbeta induces chromatin opening at a cell-type-specific enhancer.

Authors:  Annette Plachetka; Olesya Chayka; Carola Wilczek; Svitlana Melnik; Constanze Bonifer; Karl-Heinz Klempnauer
Journal:  Mol Cell Biol       Date:  2008-01-14       Impact factor: 4.272

3.  Differences in C/EBPs in normal tissue and papillomas of the larynx.

Authors:  L Jin; G Y Yang; K Auborn
Journal:  Cell Prolif       Date:  1998 Jun-Aug       Impact factor: 6.831

Review 4.  C/EBPß Isoform Specific Gene Regulation: It's a Lot more Complicated than you Think!

Authors:  Aaron J Spike; Jeffrey M Rosen
Journal:  J Mammary Gland Biol Neoplasia       Date:  2020-02-20       Impact factor: 2.673

5.  A bicistronic MAVS transcript highlights a class of truncated variants in antiviral immunity.

Authors:  Sky W Brubaker; Anna E Gauthier; Eric W Mills; Nicholas T Ingolia; Jonathan C Kagan
Journal:  Cell       Date:  2014-02-13       Impact factor: 41.582

6.  Epidermal growth factor receptor stimulation activates the RNA binding protein CUG-BP1 and increases expression of C/EBPbeta-LIP in mammary epithelial cells.

Authors:  Brenda R Baldwin; Nikolai A Timchenko; Cynthia A Zahnow
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

7.  Calreticulin interacts with C/EBPalpha and C/EBPbeta mRNAs and represses translation of C/EBP proteins.

Authors:  Lubov T Timchenko; Polina Iakova; Alana L Welm; Z-J Cai; Nikolai A Timchenko
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

8.  Eukaryotic initiation factors (eIF) 2alpha and 4E expression, localization, and phosphorylation in brain tumors.

Authors:  Sonia Tejada; M Val T Lobo; Mercedes García-Villanueva; Silvia Sacristán; M Isabel Pérez-Morgado; Matilde Salinas; M Elena Martín
Journal:  J Histochem Cytochem       Date:  2009-02-02       Impact factor: 2.479

Review 9.  The preneoplastic phenotype in murine mammary tumorigenesis.

Authors:  D Medina
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-10       Impact factor: 2.673

10.  PERK regulates the proliferation and development of insulin-secreting beta-cell tumors in the endocrine pancreas of mice.

Authors:  Sounak Gupta; Barbara McGrath; Douglas R Cavener
Journal:  PLoS One       Date:  2009-11-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.